Clinical Trial Update: A Randomized Controlled Study of Rolapitant for the Prevention of Nausea and Vomiting Following Surgery (Study P04937AM1)(COMPLETED) [Phase 2]

View source ↗

Summary

Phase 2 randomized trial evaluating rolapitant for prevention of postoperative nausea and vomiting has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Nausea and Vomiting

Drugs mentioned

• Rolapitant (rolapitant)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Postoperative Nausea and Vomiting | Phase 2 | Status: COMPLETED